glp-1 how long does it take for to start working: timeline from first dose to full results How Long Do GLP-1 Medications

Description

Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss

Key points Cardiovascular outcome trials in individuals with type 2 diabetes mellitus demonstrate that glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce the rates of non-fatal myocardial infarction, non-fatal stroke and cardiovascular death

Some women also use metformin under their doctors supervisionit does cross the placenta, but it has a good safety track record in pregnancy

However, this also depends on the type of plan and the medical history of the patient in question. In addition to weight management, Wegovy is also FDA approved to reduce the risk of major adverse cardiovascular events in adults with cardiovascular disease and either obesity or overweight